abstract |
The present invention relates to antisense oligonucleotides that modulate the expression and / or function of antiviral genes, particularly antisense oligonucleotides targeted to natural antisense polynucleotides of antiviral genes. The invention also relates to the identification of such antisense oligonucleotides and to the use thereof for the treatment of diseases and disorders associated with the expression of antiviral genes. |